Shanghai Zhezhong Group (002346.SZ) plans to spend 300 million to 330 million yuan to implement a buyback. The buyback price will not exceed 11.5 yuan per share.
Zhejiang Zhongda Group (002346.SZ) announced that the company plans to repurchase its own shares, with a minimum repurchase quantity of 300...
Shanghai Zhezhong Group (002346.SZ) announcement: The company plans to repurchase company shares, with a minimum quantity of 30 million shares and a maximum quantity of 33 million shares; the total amount of the share repurchase will not be less than RMB 300 million and not exceed RMB 330 million; the repurchase price will not exceed RMB 11.5 per share. The share repurchase implementation period is within 12 months from the date when the shareholder's meeting approves the share repurchase plan. The funds for this share repurchase will come from the company's own funds and special loans for stock repurchase.
Related Articles

Guangdong Taienkang Pharmaceutical (301263.SZ): The application for the registration and listing approval of sulfamethoxazole tablets has been accepted.

SoftBank (SFTBY.US) and OpenAI's Japan AI joint venture plan has been reported to be delayed, with new developments expected to be announced in November.

Guotai Haitong: Initiates "buy" rating on BEST PACIFIC (02111) with a target price of HK$4.42.
Guangdong Taienkang Pharmaceutical (301263.SZ): The application for the registration and listing approval of sulfamethoxazole tablets has been accepted.

SoftBank (SFTBY.US) and OpenAI's Japan AI joint venture plan has been reported to be delayed, with new developments expected to be announced in November.

Guotai Haitong: Initiates "buy" rating on BEST PACIFIC (02111) with a target price of HK$4.42.
